AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Nobeglar Injection

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Insulin Glargine (100IU)

Overview Nobeglar Injection

InsuLinR (injection) is a sustained-release insulin formulation indicated for managing type 1 and type 2 diabetes mellitus in pediatric and adult patients. Providing consistent, all-day insulin levels, it effectively regulates blood glucose, mitigating diabetic complications. InsuLinR may be administered alone or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Consistent use, as prescribed, maximizes therapeutic benefit; discontinuation may lead to dangerously elevated blood sugar and serious health risks. This medication is a component of a comprehensive diabetes management plan encompassing dietary modifications, physical activity, and weight management, as directed by your physician. Hypoglycemia (low blood sugar) is the most frequently reported adverse event. Precise dosing, regular meals, and diligent blood glucose monitoring are crucial for its prevention. Excessive alcohol consumption elevates hypoglycemia risk. Additional potential side effects include peripheral swelling, lipodystrophy, hypersensitivity reactions, injection site reactions, pruritus, skin rashes, and weight increase. Avoid use with existing hypoglycemia. Prior to treatment initiation, disclose any history of renal, hepatic, or cardiovascular disease. Consult your physician before use during pregnancy or lactation.

Uses of Nobeglar Injection

High blood sugar

Major Benefits of Nobeglar Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Nobeglar Injection:

  • Hypoglycemia (low blood glucose level)
  • Peripheral edema
  • Lipodystrophy (skin thickening or pits at the injection site)
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Rash
  • Weight gain

How to use Nobeglar Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Nobeglar Injection works:

Nobeglar Injection, a sustained-release insulin formulation, offers continuous blood glucose regulation throughout the day. Its action mimics the body's natural insulin mechanism, promoting glucose absorption into muscle and adipose tissue while simultaneously inhibiting hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Nobeglar Injection is contraindicated.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Nobeglar Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Nobeglar Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Nobeglar Injection requires careful administration in individuals with impaired kidney function. Dosage modification of Nobeglar Injection might be necessary. Physician consultation is advised. Routine blood glucose level checks are suggested to guide dosage adjustments.

LiverLiverCAUTION

Patients with hepatic impairment should receive Nobeglar Injection with careful consideration. Dosage modifications for Nobeglar Injection may be necessary. Physician consultation is advised. Routine glucose level monitoring is recommended to guide dosage adjustments.

What if you forget to take Nobeglar Injection :

Should you forget a Nobeglar Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nobeglar Injection

LabelValue
Chemical Type Modified insulin
Developing Habits No.
Treatment Category Diabetes Management
Action Class Long-acting insulin analogs

FAQs on Nobeglar Injection

Nobeglar Injection is a synthetic insulin closely resembling human insulin. Its prolonged, consistent action on blood sugar lasts a full day, allowing for once-daily administration. It's indicated for treating type 1 and type 2 diabetes mellitus in adults and children (type 1).
Nobeglar Injection is administered subcutaneously. Your doctor will demonstrate the proper injection technique and suitable sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area with each dose—for example, vary your injection location on your abdomen by approximately 1 cm each time. Alternating injection sides (e.g., right side one day, left the next) is also helpful. This rotation minimizes complications like lipodystrophy (fat tissue thickening), irritation, and pain from repeated injections at the same site. After one to two weeks, switch to a different body area as instructed by your doctor. Contact your doctor if you experience any difficulties.
Nobeglar Injection, a long-acting medication, is typically administered once daily. While the time of day is flexible, consistent daily dosing is recommended.
An accidental overdose of Nobeglar Injection can cause dangerously low blood sugar (hypoglycemia), ranging from mild to severe. Closely monitor your blood sugar levels for 24 hours. Mild hypoglycemia, with symptoms like anxiety, sweating, weakness, tremors, and rapid heartbeat, often responds to sugary foods like candy, fruit juice, or glucose tablets. However, always consult your doctor for guidance. Severe hypoglycemia can cause seizures or unconsciousness, requiring immediate emergency medical attention.
Store Nobeglar Injection in its original container, out of children's reach. Unopened vials and pens should be refrigerated, but not frozen. Use before the expiration date on the label. Discard any Nobeglar Injection that has been frozen or thawed. If refrigeration isn't possible, store unopened vials at room temperature, protected from sunlight and heat. The solution should be clear, colorless, and free of particles.
Discuss insulin dose adjustments with your doctor. This includes situations like illness (requiring closer blood sugar monitoring), changes in medication (many drugs interact with insulin), altered eating habits (missed meals, unusual food intake), exercise, alcohol use, or stress. Pregnant or breastfeeding individuals should also consult their doctor before using Nobeglar Injection, as dosage changes may be necessary.
Nobeglar Injection rarely causes serious side effects, though severe allergic reactions, characterized by rash, hives, itching, breathing difficulties (wheezing), rapid heart rate, and low blood pressure, are possible. Seek immediate medical attention if these occur. Other potential side effects include severe hypoglycemia (low blood sugar), manifesting as dizziness, sweating, anxiety, confusion, headache, blurred vision, slurred speech, tremors, rapid heartbeat, seizures, and loss of consciousness. Concurrent use of TZDs (thiazolidinediones) may increase the risk of heart failure, even in individuals without pre-existing heart conditions. Sudden weight gain and ankle or foot swelling (edema) may also occur. Report any of these side effects to your doctor promptly.
Nobeglar Injection
708
MRP 822
13% off